2021
DOI: 10.1080/14737159.2021.1920400
|View full text |Cite
|
Sign up to set email alerts
|

Novel lab-on-a-disk platforms: a powerful tool for molecular fingerprinting of oral and respiratory tract infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…This may prospectively pave the way for the more general implementation of the BFPD-IA on other NAAT devices, thereby expanding their portfolio and achieving complementary diagnostics where, for example, pathogen identification and immunological response are tested on the same instrument, with major impacts on the health economics of diagnostics. Moreover, the health systems in several areas of medicine that require such co-assessment and interoperability between microbiological and immunological outcomes [ 50 , 73 , 77 , 78 , 79 , 80 ] would benefit from such complementary diagnostics.…”
Section: Resultsmentioning
confidence: 99%
“…This may prospectively pave the way for the more general implementation of the BFPD-IA on other NAAT devices, thereby expanding their portfolio and achieving complementary diagnostics where, for example, pathogen identification and immunological response are tested on the same instrument, with major impacts on the health economics of diagnostics. Moreover, the health systems in several areas of medicine that require such co-assessment and interoperability between microbiological and immunological outcomes [ 50 , 73 , 77 , 78 , 79 , 80 ] would benefit from such complementary diagnostics.…”
Section: Resultsmentioning
confidence: 99%
“…A newly developed and tested bead-based immunoassay with oral biomarkers [ 75 ] will enable an immunoassay disk to be run in the same instrument as the PCR disk. This will increase the interoperability between immunological and microbiological diagnostic outputs using this platform [ 76 ]. Subsequently, by using combined computational technologies and the OralDisk device, new diagnostic predictive models of disease development and progression may be generated [ 73 ].…”
Section: Resultsmentioning
confidence: 99%